Meltem Avci-Adali

Meltem Avci-Adali

Department of Thoracic, University Hospital Tuebingen

Affiliated withUniversity Hospital TuebingenUniversity Hospital Tübingen

Research Area

Biography

Meltem Avci-Adali has not added Biography.
If you are Meltem Avci-Adali and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3
Year
<em>In Vitro</em> Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
Publication title

Cited by 36

2014
2022
2024

Other Publications

Article
Year
New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials.

Biomaterials| PubMed ID: 18640715

2008
Aptamers influence the hemostatic system by activating the intrinsic coagulation pathway in an in vitro Chandler-Loop model.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis| PubMed ID: 19117958

2010
2009
Endothelial progenitor cell capture stents--hype or hope?

International journal of cardiology| PubMed ID: 19576642

2010
2009
2010
2010
2010
2011
Absolute quantification of cell-bound DNA aptamers during SELEX.

Nucleic acid therapeutics| PubMed ID: 23405949

2013
2013
In vivo tissue engineering: mimicry of homing factors for self-endothelialization of blood-contacting materials.

Pathobiology : journal of immunopathology, molecular and cellular biology| PubMed ID: 23652281

2013
2013
2013
2014
2014
2014
2014
Hemocompatibility testing according to ISO 10993-4: discrimination between pyrogen- and device-induced hemostatic activation.

Materials science & engineering. C, Materials for biological applications| PubMed ID: 25063137

2014
2018
2018
Blood-Contacting Biomaterials: Evaluation of the Hemocompatibility.

Frontiers in bioengineering and biotechnology| PubMed ID: 30062094

2018
2019
Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA.

International journal of molecular sciences| PubMed ID: 30987077

2019
2019
2019
Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration.

Cellular and molecular life sciences : CMLS| PubMed ID: 31451894

2020
2019
2020
2020
2021
2021